Genitourinary Malignancies Heiko Schöder General Considerations Urologic malignancies account for approximately 25% of all new cancers in the United States (1). The clinical utility of positron emission tomography (PET) with…

PET and PET/CT in Ovarian Cancer Hedieh Eslamy Robert Bristow Richard L. Wahl Ovarian cancer accounts for about 3% of all cancers among women and ranks second in frequency among…

Cervical and Uterine Cancer Perry W. Grigsby The initial diagnosis and staging of most gynecologic malignancies are commonly achieved by history and physical examination and by use of selected imaging…

Pancreatic and Hepatobiliary Cancers Oleg Teytelboym Dominique Delbeke Richard L. Wahl Pancreatic Carcinoma Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, accounting for 5% of cancer related…

Applications for Fluorodeoxyglucose PET and PET/CT in the Evaluation of Patients with Colorectal Carcinoma Dominique Delbeke Colorectal cancer is the third most common cause of cancer in men and women,…

PET in Breast Cancers Farrokh Dehdashti Breast cancer is the most common malignancy in women, accounting for approximately 26% of all female cancers. It is estimated that in the year…

Esophagus Wolfgang A. Weber Richard L. Wahl Esophageal carcinoma is considered the eighth most common cancer worldwide with nearly 400,000 new cases diagnosed annually. However, incidence rates of esophageal cancer…

PET and PET/CT of Malignant Melanoma Hans C. Steinert Malignant melanoma is the most aggressive cancer of the skin. The incidence of cutaneous malignant melanoma among whites living in the…

Lymphoma and Myeloma S. N. Reske Malignant Lymphoma The use of positron emission tomography (PET) and PET combined with computed tomography (CT) in lymphoma management has shown remarkable growth in…

Use of PET and PET/CT in the Evaluation of Patients with Head and Neck Cancer Todd M. Blodgett Alexander Ryan Barton Branstetter IV Protocols for Evaluation of Head and Neck…